Alerce Investment Management, L.P. 13F Holdings · last filed Q4 2024
Alerce Investment Management, L.P. reported 5 securities worth $56.80M in its SEC 13F filing for Q4 2024 (period ended 2024-12-31). Top holdings: ANNX (66.89%), AKBA (19.23%), VRNA (7.19%). Among its top 25 positions this quarter: 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | ANNX | ANNEXON INC | $38.0M | 66.89% | 7.4M | Hold |
| 2 | AKBA | AKEBIA THERAPEUTICS INC | $10.9M | 19.23% | 5.7M | Hold |
| 3 | VRNA | VERONA PHARMA PLC | $4.1M | 7.19% | 88,000 | Trimmed |
| 4 | AMWL | AMERICAN WELL CORP | $3.8M | 6.69% | 523,785 | Hold |
| 5 | WHWK | AADI BIOSCIENCE INC | $2,079 | 0.00% | 659 | Hold |
Source: SEC Form 13F filings · as of 2024-12-31
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR